MAP1LC3A and Alzheimer disease: Furthermore, we found a positive correlation between these six genes and the genes encoding APP and MAPT, suggesting that FUNDC1, MAP1LC3A, CSNK2A1, VDAC1, CSNK2B, and ATG5 have the potential to be used as reliable biomarkers to successfully establish AD diagnosis.